Concepedia

Author

Norbert Frickhofen

Helios Dr. Horst Schmidt Kliniken WiesbadenORCID

Also Known As

Frickhofen, Norbert, N Frickhofen, N. Frickhofen, Norbert Frickhofen, Wolfram Jung

161

Publications

7.1K

Citations

40

H-Index

82

Concepts

All Affiliations

Helios Dr. Horst Schmidt Kliniken WiesbadenUniversität UlmHeidelberg UniversityEssen University HospitalGoethe University Frankfurt
NF

About

Norbert Frickhofen is an author at Helios Dr. Horst Schmidt Kliniken Wiesbaden specializing in medicine, oncology, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

21

30

1.6K

2

Health Sciences

10

10

1.1K

3

Cell Biology

4

4

104

4

Engineering

2

2

324

5

Biochemistry

1

1

30

Norbert Frickhofen

×

70

Publications

6.5K

Citations

35

H-Index

YearCitations

Persistent B19 Parvovirus Infection in Patients Infected with Human Immunodeficiency Virus Type 1 (HIV-1): A Treatable Cause of Anemia in AIDS

Norbert Frickhofen, Janis L. Abkowitz, Monika M. Safford,

Annals of Internal Medicine

1990

476

Treatment of Aplastic Anemia with Antilymphocyte Globulin and Methylprednisolone with or without Cyclosporine

Norbert Frickhofen, J. P. Kaltwasser, Hubert Schrezenmeier,

New England Journal of Medicine

1991

421

Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial

Christoph Röllig, Hubert Serve, Andreas Hüttmann,

The Lancet Oncology

2015

395

Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT* SAA Working Party

Andrea Bacigalupo, Jill Hows, Éliane Gluckman,

British Journal of Haematology

1988

387

Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia

Norbert Frickhofen, H. Heimpel, J. P. Kaltwasser,

Blood

2003

328

Extranodal malignant lymphoma: detection with FDG PET versus CT.

Florian Moog, Markus Bangerter, C. G. Diederichs,

Radiology

1998

321

High-Dose Chemotherapy With Autologous Stem-Cell Transplantation and Hyperfractionated Radiotherapy As First-Line Treatment of Primary CNS Lymphoma

Gerald Illerhaus, Reinhard Marks, Gabriele Ihorst,

Journal of Clinical Oncology

2006

291

18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow.

Florian Moog, Markus Bangerter, J. Kotzerke,

Journal of Clinical Oncology

1998

277

Whole-body 2-[18F]-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin’s disease

Markus Bangerter, Florian Moog, Inga Buchmann,

Annals of Oncology

1998

246

Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial

Viola Poeschel, Gerhard Held, Marita Ziepert,

The Lancet

2019

244

Page 1